| Teva Pharma AG - Temozolomid-Teva 140 mg, Kapseln | | 61225 | | 04 | | Temozolomid-Teva 140 mg | | Kapseln | | L01AX03 | | Temozolomid | | 14.10.2010 | | |
| | Composition | | temozolomidum 140 mg, lactosum 117.04 mg, carboxymethylamylum natricum A corresp. natrium 0.588 mg, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, Kapselhülle: gelatina, E 171, Drucktinte: lacca, propylenglycolum, ammonii hydroxidum, E 132, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Ammonii Hydroxidum | | | Temozolomide | 140 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Temozolomide | 140 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acidum Stearicum | | | | Acide Tartarique | | | | Carboxymethylamylum Natricum A | | | | E 132 | | color. | | E 171 | | color. | | Gelatina | | Kapselhülle | | Lacca | | Drucktinte | | Lactosum | 117.04 mg | | | Pro Capsula | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
